Circulating tumor DNA guides prognosis in metastatic triple-negative breast cancer

Grants

Funding Acknowledgements

Supported by Cancer Therapeutics CRC (A.Z.B.), the National Breast Cancer Foundation, the Victorian Cancer Agency, and the National Health and Medical Research Council of Australia (S.-J.D.).